EUVIMEDEUVIMED entdecken
Crossref

Ki-67 and p53 as Prognostic Factors for Luminal Type Breast Cancer

Ki Ho Kim, Byung Joo Chae, Byung Joo Song, Sang Seol Jung

Journal of Breast Disease · 2013

DOI: 10.14449/jbd.2013.1.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Breast Disease, 2013. Verfasst von Ki Ho Kim und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Breast cancer encompasses a heterogeneous population of tumors characterized by a variety of clinical, pathological, and molecular features.The estrogen receptor (ER) or progesterone receptor (PR) positive luminal types of breast cancer exhibits a better prognosis but are less chemosensitive.The aim of the study was to investigate the outcomes and the prognostic factors for the ER+ or PR+ luminal subtype in patients with breast cancer.

Methods

In an investigation of 405 women with breast cancer who underwent surgery from 1994 to 2000, the expressions of ER and PR, and human epidermal growth factor receptor 2 (HER2) were evaluated.Medical records were retrospectively reviewed to find clinicopathological features.The subtypes were defined as luminal-A, luminal-B according to ER+ or PR+ and HER2 status.

Results

To study subgroup analysis, the hazard ratio of the luminal A and B subtypes were 1.63 (95% confidence interval [CI], 0.46-5.73;p= 0.45) and 2.43 (95% CI, 1.44-4.09;p< 0.01), respectively.Univariate analysis showed that the pathological tumor stage and pathological axillary lymph node status were prognostic factors of recurrence-free survival (RFS) and overall survival (OS).However, expression of Ki-67 and p53 expression were associated with OS only in the univariate analysis.

Conclusion

Ki-67 expression related to important prognostic factor in terms of both the RFS and the OS in patients with breast cancer by luminal type.In subgroup analysis, Ki-67 as well as p53 were reliable as important OS prognostic factors.The results indicate that more intensive adjuvant treatment will improve OS in patients with the luminal A subtype and Ki-67 or p53 expression.

Zitieren

APA

Kim, K. H., Chae, B. J., Song, B. J., & Jung, S. S. (2013). Ki-67 and p53 as Prognostic Factors for Luminal Type Breast Cancer. Journal of Breast Disease. https://doi.org/10.14449/jbd.2013.1.3

Vancouver

Kim KH, Chae BJ, Song BJ, Jung SS. Ki-67 and p53 as Prognostic Factors for Luminal Type Breast Cancer. Journal of Breast Disease. 2013. doi:10.14449/jbd.2013.1.3

BibTeX
@article{Kim2013,
  author = {Kim, Ki Ho and Chae, Byung Joo and Song, Byung Joo and Jung, Sang Seol},
  title = {Ki-67 and p53 as Prognostic Factors for Luminal Type Breast Cancer},
  journal = {Journal of Breast Disease},
  year = {2013},
  doi = {10.14449/jbd.2013.1.3}
}
Kostenlos starten →